Testing blood or brain markers in kids with ADHD
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 8 years 0 months and 12 years 11 months 30 days
- Have ADHD diagnosis (or be a healthy control with no ADHD or other psychiatric/developmental diagnoses)
- Be mostly right-hand dominant
- Be able to take part in interviews and sign consent
- If taking ADHD stimulant medication, be willing to pause it as the study directs
- Be willing to take part in a single-dose, randomized crossover test with methylphenidate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging (MRI) to see how methylphenidate affects brain activity in people with ADHD. It may help doctors better understand how this medicine works and who benefits most.
This study tests whether CNS stimulant medications can improve irritability and aggression in children with ADHD. It looks for factors that predict who will benefit most.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
Hear when a new Attention Deficit Hyperactivity Disorder Combined trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.